Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02579421 · ClinicalTrials.gov registry record · NA
Hormones and Reduction in Co-users of Marijuana and Nicotine
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02579421 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 58 participants.
The verdict
NCT02579421, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the role of progesterone (a naturally occurring hormone found in both men and women) on reducing marijuana use. The investigators will see if progesterone effects impulsivity, withdrawal, mood and stress during marijuana cessation.
Interventions
- DRUG placebo
- DRUG Progesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-07-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02579421
The ClinicalTrials.gov registry entry for NCT02579421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02579421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02579421 about?
NCT02579421 is a clinical study titled "Hormones and Reduction in Co-users of Marijuana and Nicotine". The purpose of this study is to examine the role of progesterone (a naturally occurring hormone found in both men and women) on reducing marijuana use. The investigators will see if progesterone effects impulsivity, withdrawal, mood and stress during marijuana cessation.
What is the current status of trial NCT02579421?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2015-11. Estimated completion is 2017-07-27.
What interventions are being tested in trial NCT02579421?
The interventions under investigation include: placebo (DRUG), Progesterone (DRUG).
Who is sponsoring clinical trial NCT02579421?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.